MinervaX

THE SCIENCE WAS
READY. THE BRAND
WASN'T THERE YET.

MinervaX is developing a prophylactic vaccine against Group B Streptococcus. A breakthrough that could protect newborns, pregnant women, and adults worldwide.

VACCINE

The science was gaining traction in the biotech sector, attracting attention from investors and partners alike.

BIOTECH

But the visual identity wasn’t keeping pace. MinervaX needed a brand that looked as credible as the research behind it.

BRAND

CHALLENGE

A credible company
without a credible
brand to match.

MinervaX had built a strong reputation in biotech, but their visual identity told a different story. It looked dated, generic, forgettable.

CHALLENGE

In a sector where trust and authority are everything, first impressions matter. The brand wasn’t opening the doors the science deserved.

We needed to create a visual identity that would resonate with investors, partners, and the medical community, without losing what already worked.

APPROACH

Building on what
was already there.
Not starting over.

We worked closely with the senior team through workshops and consultations, understanding what had earned MinervaX its reputation in the first place.

The new logo – a typemark with an arrow pointing towards the ‘X’ – captures the company’s relentless progress towards its life-saving goals.

A refined blue palette and modern typography completed the system, projecting reliability and contemporary confidence across every touchpoint.

OUTCOME

A brand that opens
doors the science
deserves.

We delivered a complete visual identity system. A new logo, colour palette, typography, and imagery guidelines.

OUTCOME

Comprehensive brand guidelines covered everything from logo usage and tone of voice to messaging and implementation.

A new website gave MinervaX a digital hub to showcase its research, pipeline, and ambitions to a global audience.

A biotech pioneer now has the visual credibility to match its scientific credentials – and the tools to maintain it.

impact

A brand that earns trust at every table.

A visual identity that gives MinervaX the credibility to stand alongside global biotech leaders. In boardrooms, at conferences, and with regulators.

Investors

Continued backing

Blue-chip healthcare funds including EQT, OrbiMed, Novo Holdings, and Sanofi Ventures.

Regulators

Doors opened

Brand credibility behind successful FDA Fast Track and EMA PRIME designations.

Partners

Commercial traction

Manufacturing collaboration secured as MinervaX scales toward Phase 3 trials.

What we did

Strategy & positioning

Sector research
Brand positioning
Brand strategy
Logo development
Sub-branding

Visual & verbal identity

Tone of voice
Top-level messaging
Brand user guidelines
Digital design templates
Website development

We enjoyed working with Fabrik. No marketing jargon – just insightful strategy, fresh creative thinking, and a collaborative approach.

Fabrik crafted a distinctive new visual and verbal identity, including a logo design, tone of voice, and brand guidelines, all designed to strengthen our market presence. By drawing from our past to maintain continuity with the old MinervaX identity, they struck the perfect balance between familiarity and innovation.

Their guidance and reassurance to our senior team made the process seamless and impactful.

Per Fischer, M.Sc. D.Phil

Our Work

THE SCIENCE WAS READY. THE BRAND WASN'T THERE YET.

A credible company without a credible brand to match.

A brand that opens doors the science deserves.